Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

43.50
Delayed Data
As of 12:58pm ET
 -1.42 / -3.16%
Today’s Change
30.13
Today|||52-Week Range
52.58
-14.45%
Year-to-Date

Today’s Trading

Previous close44.92
Today’s open45.00
Day’s range43.32 - 45.00
Volume94,219
Average volume (3 months)309,678
Market cap$841.0M
Dividend yield--
Data as of 12:58pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+168.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.94%
P/E ratio7.4
Price/Sales15.90
Price/Book5.63

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.22-1.32%
SGYPSynergy Pharmaceutic...+0.16+1.76%
FLMLFlamel Technologies ...+0.20+0.97%
SUPNSupernus Pharmaceuti...-0.21-1.24%
Data as of 1:13pm ET, 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.26
Annual revenue (last year)$47.7M
Annual profit (last year)$34.4M
Net profit margin72.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
Chief Financial Officer &
Senior VP-Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers